TGF- and TNF- production is decreased rendering a drop in HSC activation, and consequently, less fibrosis

TGF- and TNF- production is decreased rendering a drop in HSC activation, and consequently, less fibrosis. showing a strong correlation between mRNA expression and enzyme activity. CONCLUSION: Our results suggest that CFA inhibits the transcriptional factor Snail-1, down-regulating profibrogenic genes, and activates Nrf2 inducing CC-90003 antioxidant enzymes system, preventing inflammation and fibrosis. Keywords:Liver fibrosis, Caffeine, Thioacetamide, Bile duct ligation, Profibrogenic genes, Proinflammatory cytokines, Antioxidant enzymes Core tip:This paper shows the protective effect of caffeine in the liver to the constant aggressiveness of a hepatotoxic. Here we present evidence not published before of some molecular mechanisms like inhibition of Snail-1 and activation of Nrf2 that could be involved in this beneficial effect down-regulating pro-fibrogenic genes and up-regulating antioxidant molecules. == INTRODUCTION == The liver performs essential functions in the body[1]. Hepatic stellate cells (HSC) are key in the fibrogenic process[2]. After stimulation of liver damage, HSC undergo a process called activation; characterized by synthesis of type I and III collagens[3-5]. This state of activation is maintained by growth factors such as transforming growth factor 1 (TGF-1)[6], connective tissue growth factor (CTGF)[7], and pro-inflammatory molecules such as tumor necrosis factor alpha (TNF-), interleukin-1 (IL-1), interleukin 6 (IL-6)[8] and reactive oxygen species (ROS). Epidemiological studies had associated caffeine (CFA) consumption with protection against development of chronic liver disease or reduction of disease severity[9-11].In vitrostudies have shown beneficial effects of CFA, that can be useful in preventing HSC activation and perpetuation of this state[12,13]. Among CFA effects observedin vitroare: inhibition of expression of CTGF[14-16]; reduction of pro-inflammatory cytokines expression such as TNF-, IL-1 and IL-6 by mechanisms not yet defined[8], and CFA antioxidant effect[17-21]. On the other hand, a potent natural antioxidant, quercetin increases the transcriptional and translational activity of the transcriptional factor Nrf2 which has potent antioxidant activity[22]. Activation of HSC is a complex process where the transcriptional factor Snail-1 has an important role. Several authors have reported the overexpression of Snail-1 in pathological conditions associated with extracellular matrix (ECM) deposition[23,24]. Snail-1 expression has been shown in cholangiocytes and hepatocytes of fibrotic livers[14,16], and recently, Snail-1 has been published as Mouse monoclonal antibody to Pyruvate Dehydrogenase. The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzymecomplex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), andprovides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDHcomplex is composed of multiple copies of three enzymatic components: pyruvatedehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase(E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodesthe E1 alpha 1 subunit containing the E1 active site, and plays a key role in the function of thePDH complex. Mutations in this gene are associated with pyruvate dehydrogenase E1-alphadeficiency and X-linked Leigh syndrome. Alternatively spliced transcript variants encodingdifferent isoforms have been found for this gene a central transcription factor on the activation of HSC demonstrating its essential role in regulating the liver fibrosis process[25]. According to our findings, CFA-mediated molecular mechanisms comprise in part down-regulation of profibrogenic genes, diminishing of inflammatory cell infiltrate, down-regulation of pro-inflammatory cytokines, and up-regulation of antioxidant enzymes. Our results suggest that these events could be mediated, at least in part, by Nrf2 activation and inhibition of Snail-1 which are key factors in the development of this process. == MATERIALS AND METHODS == == Materials == CFA was acquired from Sigma Aldrich Co., (St Louis Missouri). Thioacetamide (TAA) was purchased from Merck Company, (Darmstadt, Germany). CD11b antibody was obtained from Biolegend (San Diego, CA, United States). Biotinylated secondary antibody and avidin-conjugated peroxidase were obtained from Vector Laboratories (Burlingame, CA, United States). DuoSet enzyme-linked immunosorbant assay (ELISA) Development kit was acquired from R and D Systems, (Minneapolis, United States). Primers and probes to create real-time polymerase chain response CC-90003 (PCR) were obtained from Applied Biosystems (Hammonton, NJ, USA). Poly vinylidene fluoride (PVDF) membranes (Bio-Rad Laboratories, Hercules CA, USA). Nrf2, Snail-1 and supplementary antibodies were bought from Avcam Inc (Cambridge MA, USA). == Pets and experimental style == Wistar rats found in this research were extracted from Charles Streams (Boston, MA, USA) and housed based on the Pet Care protocol CC-90003 set up by School of Guadalajara. Thirty male Wistar rats, weighing 250-280 g had been split into three groupings (10 rats in each group) the following: (1) healthful (n= 10); (2) TAA (n= 10), rats with intraperitoneal TAA to build up liver organ fibrosis; and (3) bile duct ligation (BDL) (n= 20), rats that underwent a BDL and laparotomy. Finally 5 rats of every group had been treated with CFA and various other 5 rats received automobile just (fibrotic rats). == CFA administration in TAA-intoxicated and BDL rats == Twoin vivomodels had been intended.